Familial correlations, segregation analysis, and nongenetic correlates of soy isoflavone-metabolizing phenotypes - PubMed (original) (raw)
Familial correlations, segregation analysis, and nongenetic correlates of soy isoflavone-metabolizing phenotypes
C L Frankenfeld et al. Exp Biol Med (Maywood). 2004 Oct.
Erratum in
- Exp Biol Med (Maywood). 2004 Dec;229(11):1206
Abstract
Particular intestinal bacteria metabolize the soy isoflavone daidzein to equol and O-desmethylangolensin (O-DMA), metabolites that can be identified in urine. Individuals that harbor bacteria capable of producing equol or O-DMA are known as equol producers (approximately 30%-50% of the population) and O-DMA producers (approximately 80%-90% of the population), respectively. The equol-producer phenotype has been associated with sex hormone-related outcomes in several studies. However, the bacteria responsible for these phenotypes have not yet been identified and factors that influence the manifestation of these phenotypes are not well understood. To evaluate familial clustering of and nongenetic factors associated with these phenotypes, 410 individuals from 112 families participated in phenotyping (3-day soy challenge and Day 4 spot urine collection). In segregation analyses of the equol-producer phenotype, the Mendelian dominant model provided the most parsimonious fit to the data, suggesting that the pattern of inheritance of the equol-producer phenotype is consistent with an autosomal dominant trait. This phenotype was positively associated with education (p trend = 0.01), but not with sex, smoking, or several dietary factors. Results of the segregation analyses of the O-DMA-producer phenotype were inconclusive; no other models provided a more parsimonious fit to the data than the general model. This phenotype was inversely associated with age in a nonlinear model (p = 0.01), positively associated with age- and sex-adjusted height (odds ratio [OR] 10-cm increase = 0.38, 95% confidence interval [CI] = 0.15, 0.95) and body mass index (kg/m(2)) (OR = 0.91, 95% CI = 0.85, 0.96), but not with sex, education, smoking, or several dietary factors. These results suggest the equol-producer phenotype may be under some degree of genetic control and that there are likely other environmental factors not evaluated in the present analysis that contribute to both of these phenotypes. These results provide a foundation for further work to refine our understanding of heritable and environmental determinants of daidzein-metabolizing phenotypes.
Similar articles
- Postmenopausal bone mineral density in relation to soy isoflavone-metabolizing phenotypes.
Frankenfeld CL, McTiernan A, Thomas WK, LaCroix K, McVarish L, Holt VL, Schwartz SM, Lampe JW. Frankenfeld CL, et al. Maturitas. 2006 Feb 20;53(3):315-24. doi: 10.1016/j.maturitas.2005.05.016. Epub 2005 Jul 12. Maturitas. 2006. PMID: 16019168 - High concordance of daidzein-metabolizing phenotypes in individuals measured 1 to 3 years apart.
Frankenfeld CL, Atkinson C, Thomas WK, Gonzalez A, Jokela T, Wähälä K, Schwartz SM, Li SS, Lampe JW. Frankenfeld CL, et al. Br J Nutr. 2005 Dec;94(6):873-6. doi: 10.1079/bjn20051565. Br J Nutr. 2005. PMID: 16351761 - Obesity prevalence in relation to gut microbial environments capable of producing equol or O-desmethylangolensin from the isoflavone daidzein.
Frankenfeld CL, Atkinson C, Wähälä K, Lampe JW. Frankenfeld CL, et al. Eur J Clin Nutr. 2014 Apr;68(4):526-30. doi: 10.1038/ejcn.2014.23. Epub 2014 Feb 26. Eur J Clin Nutr. 2014. PMID: 24569543 Free PMC article. - Gut bacterial metabolism of the soy isoflavone daidzein: exploring the relevance to human health.
Atkinson C, Frankenfeld CL, Lampe JW. Atkinson C, et al. Exp Biol Med (Maywood). 2005 Mar;230(3):155-70. doi: 10.1177/153537020523000302. Exp Biol Med (Maywood). 2005. PMID: 15734719 Review. - O-desmethylangolensin: the importance of equol's lesser known cousin to human health.
Frankenfeld CL. Frankenfeld CL. Adv Nutr. 2011 Jul;2(4):317-24. doi: 10.3945/an.111.000539. Epub 2011 Jun 28. Adv Nutr. 2011. PMID: 22332073 Free PMC article. Review.
Cited by
- Equol: history, chemistry, and formation.
Setchell KD, Clerici C. Setchell KD, et al. J Nutr. 2010 Jul;140(7):1355S-62S. doi: 10.3945/jn.109.119776. Epub 2010 Jun 2. J Nutr. 2010. PMID: 20519412 Free PMC article. Review. - Targeted Approaches for In Situ Gut Microbiome Manipulation.
Cresci GAM, Lampe JW, Gibson G. Cresci GAM, et al. JPEN J Parenter Enteral Nutr. 2020 May;44(4):581-588. doi: 10.1002/jpen.1779. Epub 2020 Feb 6. JPEN J Parenter Enteral Nutr. 2020. PMID: 32027044 Free PMC article. - Validation of soy protein estimates from a food-frequency questionnaire with repeated 24-h recalls and isoflavonoid excretion in overnight urine in a Western population with a wide range of soy intakes.
Jaceldo-Siegl K, Fraser GE, Chan J, Franke A, Sabaté J. Jaceldo-Siegl K, et al. Am J Clin Nutr. 2008 May;87(5):1422-7. doi: 10.1093/ajcn/87.5.1422. Am J Clin Nutr. 2008. PMID: 18469267 Free PMC article. - Regulation of the neuroendocrine axis in male rats by soy-based diets is independent of age and due specifically to isoflavone action†.
Jeminiwa BO, Knight RM, Braden TD, Cruz-Espindola C, Boothe DM, Akingbemi BT. Jeminiwa BO, et al. Biol Reprod. 2020 Oct 5;103(4):892-906. doi: 10.1093/biolre/ioaa101. Biol Reprod. 2020. PMID: 32520353 Free PMC article. - Urinary isoflavonoids and risk of coronary heart disease.
Zhang X, Gao YT, Yang G, Li H, Cai Q, Xiang YB, Ji BT, Franke AA, Zheng W, Shu XO. Zhang X, et al. Int J Epidemiol. 2012 Oct;41(5):1367-75. doi: 10.1093/ije/dys130. Epub 2012 Aug 27. Int J Epidemiol. 2012. PMID: 22927214 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources